These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26342921)

  • 21. Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial.
    Branche AR; Walsh EE; Vargas R; Hulbert B; Formica MA; Baran A; Peterson DR; Falsey AR
    J Infect Dis; 2015 Dec; 212(11):1692-700. PubMed ID: 25910632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic value of serum procalcitonin in identifying the etiology of non-responding community-acquired pneumonia after initial antibiotic therapy].
    Wang Z; Zhang X; Wu J; Zhang W; Kuang H; Li X; Xuan W; Wang K; Ma L
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Nov; 37(11):824-30. PubMed ID: 25604112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of Discordant Procalcitonin Use at an Academic Medical Center.
    Seymann GB; Bevins N; Wu C; Fitzgerald R
    Am J Clin Pathol; 2022 Jun; 157(6):890-898. PubMed ID: 34894127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of multiplex molecular assay turn-around-time on antibiotic utilization and clinical management of hospitalized children with acute respiratory tract infections.
    Lee BR; Hassan F; Jackson MA; Selvarangan R
    J Clin Virol; 2019 Jan; 110():11-16. PubMed ID: 30502640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of multiplexed respiratory viral panels on infection control measures and antimicrobial stewardship: a review of the literature.
    Wils J; Saegeman V; Schuermans A
    Eur J Clin Microbiol Infect Dis; 2022 Feb; 41(2):187-202. PubMed ID: 34799754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study).
    Henley J; Brookes-Howell L; Euden J; Pallmann P; Llewelyn M; Howard P; Powell N; Dark P; Szakmany T; Hellyer TP; Albur M; Hamilton R; Prestwich G; Ogden M; Maboshe W; Sandoe J; Thomas-Jones E; Carrol E; ;
    BMJ Open; 2023 Dec; 13(12):e077117. PubMed ID: 38114276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procalcitonin-guided antibiotic therapy: an expert consensus.
    Bartoletti M; Antonelli M; Bruno Blasi FA; Casagranda I; Chieregato A; Fumagalli R; Girardis M; Pieralli F; Plebani M; Rossolini GM; Sartelli M; Viaggi B; Viale P; Viscoli C; Pea F
    Clin Chem Lab Med; 2018 Jul; 56(8):1223-1229. PubMed ID: 29874192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials.
    Meier MA; Branche A; Neeser OL; Wirz Y; Haubitz S; Bouadma L; Wolff M; Luyt CE; Chastre J; Tubach F; Christ-Crain M; Corti C; Jensen JS; Deliberato RO; Kristoffersen KB; Damas P; Nobre V; Oliveira CF; Shehabi Y; Stolz D; Tamm M; Mueller B; Schuetz P
    Clin Infect Dis; 2019 Jul; 69(3):388-396. PubMed ID: 30358811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of a Pharmacist-Managed Procalcitonin Program on COVID-19 Respiratory Tract Infection Outcomes and Health Care Resource Utilization.
    Fratoni AJ; Kois AK; Colmerauer JL; Linder KE; Nicolau DP; Kuti JL
    Open Forum Infect Dis; 2022 Sep; 9(9):ofac468. PubMed ID: 36176570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ability of procalcitonin to distinguish between bacterial and nonbacterial infection in severe acute exacerbation of chronic obstructive pulmonary syndrome in the ICU.
    Daubin C; Fournel F; Thiollière F; Daviaud F; Ramakers M; Polito A; Flocard B; Valette X; Du Cheyron D; Terzi N; Fartoukh M; Allouche S; Parienti JJ;
    Ann Intensive Care; 2021 Mar; 11(1):39. PubMed ID: 33675432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Use of Procalcitonin for Prediction of Pulmonary Bacterial Coinfection in Children With Respiratory Failure Associated With Viral Bronchiolitis.
    Ericksen RT; Guthrie C; Carroll T
    Clin Pediatr (Phila); 2019 Mar; 58(3):288-294. PubMed ID: 30547669
    [No Abstract]   [Full Text] [Related]  

  • 32. Is there a role for procalcitonin determination in avoiding unnecessary exposure to antibiotics in a non-intensive care setting?
    Giacomelli A; van den Bogaart L; Corbellino M; Oreni L; Dolci A; Panteghini M; Rizzardini G; Galli M; Antinori S
    Infez Med; 2019 Jun; 27(2):128-133. PubMed ID: 31205034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections.
    Drozdov D; Dusemund F; Müller B; Albrich WC
    Antibiotics (Basel); 2013 Jan; 2(1):1-10. PubMed ID: 27029288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial.
    Lhopitallier L; Kronenberg A; Meuwly JY; Locatelli I; Dubois J; Marti J; Mueller Y; Senn N; D'Acremont V; Boillat-Blanco N
    BMC Pulm Med; 2019 Aug; 19(1):143. PubMed ID: 31387559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy.
    Quenot JP; Luyt CE; Roche N; Chalumeau M; Charles PE; Claessens YE; Lasocki S; Bedos JP; Péan Y; Philippart F; Ruiz S; Gras-Leguen C; Dupuy AM; Pugin J; Stahl JP; Misset B; Gauzit R; Brun-Buisson C
    Ann Intensive Care; 2013 Jul; 3(1):21. PubMed ID: 23830525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Respiratory Viral Panel Polymerase Chain Reaction Assay Turnaround Time on Length of Stay and Antibiotic Use in Patients With Respiratory Viral Illnesses.
    Choi S; Kabir R; Gautam-Goyal P; Malhotra P
    Hosp Pharm; 2017 Oct; 52(9):640-644. PubMed ID: 29276302
    [No Abstract]   [Full Text] [Related]  

  • 37. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
    Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
    Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials.
    Schuetz P; Bolliger R; Merker M; Christ-Crain M; Stolz D; Tamm M; Luyt CE; Wolff M; Schroeder S; Nobre V; Reinhart K; Branche A; Damas P; Nijsten M; Deliberato RO; Verduri A; Beghé B; Cao B; Shehabi Y; Jensen JS; Beishuizen A; de Jong E; Briel M; Welte T; Mueller B
    Expert Rev Anti Infect Ther; 2018 Jul; 16(7):555-564. PubMed ID: 29969320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Provider Decisions to Treat Respiratory Illnesses with Antibiotics: Insights from a Randomized Controlled Trial.
    Branche AR; Walsh EE; Jadhav N; Karmally R; Baran A; Peterson DR; Falsey AR
    PLoS One; 2016; 11(4):e0152986. PubMed ID: 27043012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.